Work

Combination tyrosine kinase inhibitors and PARP inhibition in TP53-mutated endometrial carcinoma

Year: 2026

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2026.01.263

Authors: Jovanka Ravix, Mary Ann Sanchez Bautista, Ariel Bengelsdorf, Elizabeth Smith, Matthew Schlumbrecht, Sophia George

Institutions: University of Miami, Sylvester Comprehensive Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7155404493

FWCI:

Cites:

Cited by:

Related to: 10